Medical News

Simian Version of HIV Vaccine Shows Success; Human Version to Be Developed, Tested

From Henry J. Kaiser Family Foundation

September 17, 2013

The New York Times reports on the study of a vaccine tested in monkeys infected with simian immunodeficiency virus (SIV), a close relative of HIV, which showed nine of the 16 monkeys given the vaccine "slowly 'cleared' the virus and now appear to be cured." SIV vaccines often are used as models for HIV vaccines, but "[n]ever before has one eliminated an existing infection," the newspaper notes. Louis Picker, a vaccine researcher at Oregon Health & Science University who led the study published last week in Nature, said a human version of the vaccine should take up to three years to prepare, according to the newspaper (McNeil, 9/16).

Back to other news for September 2013

This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.

Circulating Memory T Follicular Helper Cells Correlate With the Development of Broadly Neutralizing Antibody Responses Against HIV

Lack of Efficacy and Safety Concerns Blight Adenovirus Vaccine Vectors

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.

No comments have been made.

Add Your Comment:

(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Advertisement:
Single-Tablet Regimen for HIV-1
Learn more about the mechanism of action >

UNBP0870 11/14

What Does 2015 Hold in Store for HIV Research?

Antiretroviral Neurotoxicity May Cause Cognitive Problems

Test for HIV, Hepatitis C and Hepatitis B Approved by FDA

Exercise's Potential Impact on Inflammation and Mood

The Cynical Connectedness of Gilead's Hepatitis C Pricing and Anti-Diversion Policies

More >>

TheBodyPRO.com is a service of Remedy Health Media, LLC, 750 3rd Avenue, 6th Floor, New York, NY 10017. TheBodyPRO.com and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of TheBodyPRO.com's homepage, topic pages, page designs and HTML code. General Disclaimer: TheBodyPRO.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBodyPRO.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.